If we agree to start Trifluridine does that make us not eligible for clinical trial or second opinion? We could just...

I want to address your question directly and compassionately, because this is clearly urgent with your daughter's wedding in two weeks and your husband needing to feel his best.

Let me clarify the treatment decision framework:

Starting trifluridine-tipiracil (TAS-102) does NOT close doors:

• You can absolutely stop it if you want to pursue a clinical trial
• You can absolutely stop it to get a second opinion
• Starting one treatment doesn't make you ineligible for trials or consultations
• Many patients do exactly this—try a treatment, then pivot based on new information

However, here's what matters for YOUR situation:

Your husband's genomic results are actually quite significant. He has:

• BRCA1 mutation (Q1756fs*74) - this is a pathogenic mutation
• HRD signature positive - indicates homologous recombination deficiency
• Microsatellite stable (not MSI-high)

According to NCCN Guidelines for gastric/gastroesophageal cancers, BRCA1 mutations in metastatic disease may open access to:

1. PARP inhibitors (like olaparib) - specifically FDA-approved for BRCA-mutant cancers
2. Platinum-based chemotherapy (which he may have already received with CAPOX)
3. Clinical trials targeting HRD-positive tumors

The real question isn't whether to start trifluridine—it's whether his oncologist has discussed BRCA-directed therapy.

---

What I'd recommend you do RIGHT NOW (not what I'd do if he were my husband—that's not my role—but what the evidence suggests):

Before starting ANY new treatment:

1. Ask his oncologist explicitly: "Given his BRCA1 mutation and HRD-positive status, have we considered PARP inhibitors or other targeted approaches? Why or why not?"

2. Request a genetics consultation if he hasn't had one—a genetic counselor can discuss implications and treatment options specific to BRCA mutations.

3. Ask about clinical trials: "Are there trials for BRCA-mutant metastatic duodenal cancer he might qualify for?" (ClinicalTrials.gov is searchable by mutation type)

4. Get that second opinion—but do it strategically: A GI oncologist or medical oncologist at a major cancer center (yes, you can pay privately in Canada) should review:

   • His genomic results
   • His imaging progression
   • Whether PARP inhibitors or other targeted therapy makes sense BEFORE or INSTEAD OF trifluridine

5. Timeline consideration: Two weeks is tight. A second opinion might take 1-2 weeks to arrange. You could:

   • Request an urgent appointment
   • Have records sent ahead
   • Do a virtual consultation if needed

---

About trifluridine specifically:

According to ASCO Guidelines, TAS-102 is typically considered for microsatellite-stable metastatic gastric/duodenal cancers after prior chemotherapy. But with his BRCA mutation, his oncologist should explain why this is being recommended over BRCA-directed approaches.

The honest answer: I can't tell you what to do. But I can tell you that his genomic profile suggests there may be more targeted options worth exploring before committing to trifluridine. That's worth a conversation with a specialist who knows his full case.

---

Practical next steps for the wedding:

• Strength/energy: Ask his oncologist about managing side effects and fatigue—this matters for two weeks from now
• Timing: If you're considering a second opinion, start that process this week
• Treatment start: You don't have to decide on trifluridine today. Get the second opinion first, then decide

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

I recognize this is emotionally heavy alongside a family celebration. Your instinct to get a second opinion and explore all options is sound. Would it help to talk through what specific questions to ask at that consultation?